Abstract
The pre-apheresis peripheral blood CD34+ cell count (PBCD34) is the strongest predictor of the number of stem cells collected. It is common practice to apherese only when PBCD34 is ⩾5/μl to avoid poor yields. However, in patients with compromised marrow function, the only way to get enough cells is to collect small numbers daily several times. Another pitfall with this practice is not accounting for weight. We studied 285 autologous collections performed with PBCD34 <5/μl. The blood volume processed was 15 l (n=68) or 20 l (n=217). A collection of ⩾0.3 × 106 CD34+ cells per kg ideal body weight (IBW) was considered acceptable as this daily yield over a week could total ⩾2 × 106/kg—enough for an autograft. Two hundred and four harvests (72%) had yields of ⩾0.3; with 59% being ⩾0.4, 47% being ⩾0.5 and 36% being ⩾0.6. There were 23 patients whose harvests done when PBCD34 was low totaled ⩾2 × 106/kg. Assuming a 20-l apheresis with 70% collection efficiency, we suggest harvesting if 14 n/w ⩾0.3, where n=PBCD34 and w=IBW. This approach is more logical than using an absolute threshold, and will ensure that patients are not deprived of the opportunity of stem cell collection and autotransplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961–3969.
Ali MY, Oyama Y, Monreal J, Winter JN, Tallman MS, Williams SF et al. Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation? Bone Marrow Transplant 2003; 31: 861–864.
Elliott C, Samson DM, Armitage S, Lyttelton MP, McGuigan D, Hargreaves R et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996; 14: 970–973.
Mehta J, Oyama Y, Winter J, Williams S, Tallman M, Singhal S et al. CD34+ cell collection efficiency does not correlate with the pre-leukapheresis hematocrit. Bone Marrow Transplant 2001; 28: 597–601.
Gidron A, Verma A, Doyle M, Evens A, Gordon L, Singhal S et al. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? Bone Marrow Transplant 2005; 35: 243–246.
Pérez-Simón JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L et al. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998; 38: 385–391.
Basquiera AL, Abichain P, Damonte JC, Ricchi B, Sturich AG, Palazzo ED et al. The number of CD34+ cells in peripheral blood as a predictor of the CD34+ yield in patients going to autologous stem cell transplantation. J Clin Apher 2006; 21: 92–95.
Kim MK, Kim S, Jang G, Lee SS, Sym SJ, Lee DH et al. A randomized comparison of peripheral blood hematopoietic progenitor cell level of 5/mm3 versus 50/mm3 as a surrogate marker to initiate efficient autologous blood stem cell collection. J Clin Apher 2007; 22: 277–282.
Rick O, Beyer J, Kingreen D, Kühl JS, Zingsem J, Huhn D et al. Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization. Ann Hematol 2000; 79: 681–686.
Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini A et al. Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood 2003; 102: 1595–1600.
Goterris R, Hernández-Boluda JC, Teruel A, Gómez C, Lis MJ, Terol MJ et al. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant 2005; 36: 847–853.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gidron, A., Singh, V., Egan, K. et al. Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?. Bone Marrow Transplant 42, 439–442 (2008). https://doi.org/10.1038/bmt.2008.187
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.187
Keywords
This article is cited by
-
Cytarabine assures a high concentration of circulating CD34+ cells during haematopoietic stem cells mobilization in lymphoma patients
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine (2017)
-
Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma
Bone Marrow Transplantation (2010)